| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP And COO
1 company
Wolff Stefani is an EVP And COO at Nurix Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $114K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2023 | NRIX Nurix Therapeutics, Inc. | EVP And COO | Sale+OE | 342 | $9.88 | $3,377.69 | -5.3% | -1.9% | +21.4% | |
| Jan 30, 2023 | NRIX Nurix Therapeutics, Inc. | EVP And COO | Sale+OE | 424 | $11.78 | $4,994.55 | -9.7% | -16.6% | -32.7% | |
| Oct 31, 2022 | NRIX Nurix Therapeutics, Inc. | EVP And COO | Sale+OE | 350 | $12.88 | $4,508.18 | -9.3% | -6.8% | -56.1% | |
| Aug 1, 2022 | NRIX Nurix Therapeutics, Inc. | EVP And COO | Sale+OE | 356 | $15.67 | $5,578.52 | -22.3% | -17.4% | -38.4% | |
| May 2, 2022 | NRIX Nurix Therapeutics, Inc. | EVP And COO | Sale+OE | 330 | $11.75 | $3,877.50 | -34.3% | +28.8% | -21.4% |